BlackRock’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.19B | Sell |
|
|||||
|
2025
Q2 | $1.32B | Buy |
|
|||||
|
2025
Q1 | $1.68B | Buy |
|
|||||
|
2024
Q4 | $1.55B | Buy |
|
|||||
|
2024
Q3 | $1.59B | Sell |
|
|||||
|
2024
Q2 | $1.87B | Buy |
|
|||||
|
2024
Q1 | $1.26B | Sell |
|
|||||
|
2023
Q4 | $1.42B | Buy |
|
|||||
|
2023
Q3 | $1.29B | Buy |
|
|||||
|
2023
Q2 | $1.21B | Sell |
|
|||||
|
2023
Q1 | $1.42B | Buy |
|
|||||
|
2022
Q4 | $1.5B | Buy |
|
|||||
|
2022
Q3 | $1.21B | Sell |
|
|||||
|
2022
Q2 | $1.19B | Buy |
|
|||||
|
2022
Q1 | $1.08B | Buy |
|
|||||
|
2021
Q4 | $1.23B | Sell |
|
|||||
|
2021
Q3 | $1.18B | Buy |
|
|||||
|
2021
Q2 | $1.08B | Sell |
|
|||||
|
2021
Q1 | $1.05B | Sell |
|
|||||
|
2020
Q4 | $1.29B | Buy |
|
|||||
|
2020
Q3 | $1.11B | Sell |
|
|||||
|
2020
Q2 | $1.97B | Buy |
|
|||||
|
2020
Q1 | $1.23B | Buy |
|
|||||
|
2019
Q4 | $1.1B | Buy |
|
|||||
|
2019
Q3 | $870M | Buy |
|
|||||
|
2019
Q2 | $1.1B | Buy |
|
|||||
|
2019
Q1 | $1.12B | Sell |
|
|||||
|
2018
Q4 | $1.16B | Sell |
|
|||||
|
2018
Q3 | $1.37B | Buy |
|
|||||
|
2018
Q2 | $1.24B | Buy |
|
|||||
|
2018
Q1 | $1.04B | Sell |
|
|||||
|
2017
Q4 | $1.14B | Buy |
|
|||||
|
2017
Q3 | $1.11B | Buy |
|
|||||
|
2017
Q2 | $1.04B | Buy |
|
|||||
|
2017
Q1 | $971M | Buy |
|
|||||
|
2016
Q4 | $12.9M | Buy |
|
|||||
|
2016
Q3 | $13.7M | Buy |
|
|||||
|
2016
Q2 | $10.7M | Sell |
|
|||||
|
2016
Q1 | $12.8M | Buy |
|
|||||
|
2015
Q4 | $15.5M | Buy |
|
|||||
|
2015
Q3 | $10.5M | Sell |
|
|||||
|
2015
Q2 | $19.7M | Sell |
|
|||||
|
2015
Q1 | $34.1M | Buy |
|
|||||
|
2014
Q4 | $17.5M | Sell |
|
|||||
|
2014
Q3 | $20.9M | Sell |
|
|||||
|
2014
Q2 | $19.2M | Sell |
|
|||||
|
2014
Q1 | $27.7M | Buy |
|
|||||
|
2013
Q4 | $15.4M | Buy |
|
|||||
|
2013
Q3 | $5.91M | Buy |
|
|||||
|
2013
Q2 | $3.06M | Buy |
|